-
Versum Materials Says Revised Merck KGaA Buyout Proposal 'Superior' To Entegris Offer
Monday, April 8, 2019 - 5:07pm | 292Read More...Versum Materials, Inc. (NYSE: VSM) announced Monday that it received a revised proposal from Merck KGaA to acquire Versum for $53 per share, up from Merck's prior $48-per-share proposal on Feb. 27. What Happened Versum said its board, in consultation with legal and financial...
-
Exclusive: Ziopharm Oncology CEO Wants To Disrupt The CAR-T Supply Chain
Monday, April 16, 2018 - 8:11am | 1401Read More...Ziopharm Oncology Inc. (NASDAQ: ZIOP) has two goals. One is to disrupt the narrative around recurrent glioblastomas. The other is to disrupt the entire pharmaceutical supply chain. The latter pursuit isn’t just a B2B revenue opportunity, it's meant to alleviate cost barriers to critical...
-
Leerink Swann Suspends Millipore (MIL) Rating After Acquisition Announced
Monday, March 1, 2010 - 9:18am | 121Read More...Leerink Swann analysts Isaac Ro and Jeff Ares suspended their rating of Millipore Corporation (NYSE: MIL) due to the pending acquisition of the company by Germany's Merck KGaA. The analysts said that they would, "no longer put forth a valuation on MIL shares as our rating is suspended due to the...
